RecallRadar

FDA Drug recall D-1274-2020

Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 0143-2112-05), Rx only…

On 2020-06-03 the FDA classified a Class II recall of Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 0143-2112-05), Rx only… by West Ward Columbus, citing failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1274-2020
ClassificationClass II
Statusterminated
Initiated2020-05-13
Published2020-06-03
Last updated2026-09-13 11:52 UTC
CompanyWest Ward Columbus
DistributionUS

Product

Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 0143-2112-05), Rx only, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724.

Reason

Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.

Identifiers

ndc0143-2112-50
ndc0143-2112-05
ndc0143-2112-20
code_infoLot #: a) 71846B, Exp 6/2021; b) 71726A, Exp 6/2020; 71846B, 71853A, Exp 6/2021

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1274-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.